Doom or boom?
With the recent introduction of the European Union's Product Safety Directive, Marcus Alcock reports on the changes being made in the product liability market
It was a Monday afternoon in an ordinary hospital in an otherwise unremarkable part of north-west London. Yet, within hours of entering Northwick Park Hospital last month, six people were rushed to intensive care after taking part in the first human trials of a new anti-inflammatory drug manufactured by German pharmaceutical company TeGenero. Such was the severity of the reaction felt by the participants in the clinical trial that, according to trial volunteer Raste Khan: "some screamed out that
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.
You are currently unable to print this content. Please contact info@insuranceage.co.uk to find out more.
You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.
Copyright Infopro Digital Limited. All rights reserved.
As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (point 2.4), printing is limited to a single copy.
If you would like to purchase additional rights please email info@insuranceage.co.uk
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. As outlined in our terms and conditions, https://www.infopro-digital.com/terms-and-conditions/subscriptions/ (clause 2.4), an Authorised User may only make one copy of the materials for their own personal use. You must also comply with the restrictions in clause 2.5.
If you would like to purchase additional rights please email info@insuranceage.co.uk
More on E-Trading
Polaris at 30 – Phil Bayles
In the final day of the Polaris at 30 Q&A series Ardonagh’s Phil Bayles assesses the development of digital trading from slow, cumbersome and inflexible systems to becoming mainstream.
Polaris at 30 – Derek Cowie
Derek Cowie started working at General Accident (now Aviva) in 1992. Polaris was founded in 1994 launching digital trading platform imarket in 2004.
Polaris at 30 – Theo Duchen
Acturis Group co-CEO Theo Duchen delivers the third Q&A of the Polaris at 30 series and details the collective goal that would put “the UK light years ahead of any other market”.
Polaris at 30 – Stuart Reid
In the second Q&A instalment of the Polaris at 30 series, chair of Partners& Stuart Reid shares memories of the industry moving from paper rating guides to digital trading and his view on the “plainly daft” frustration in e-trading today.
Polaris at 30 – Ray Vincent
As insurance industry owned Polaris celebrates its 30th birthday, Insurance Age asks experts for their recollections on the dawn of digital trading and what is coming next.
Polaris at 30 – managing director Vivek Banga
Ahead of a week-long ‘Polaris at 30’ series Insurance Age caught up with managing director Vivek Banga to run the rule over the history of e-trading developments and what is coming next for brokers.
Broker Insights launches in the US
Insurtech Broker Insights has launched in the US following research and collaboration during which time it analysed almost $1bn (£770m) of gross written premiums.
Broker Expo 2024: Education part of solution to cyber cover confusion
Specialist insurers can provide cyber cover expertise and training to brokers to build confidence, according to experts at the Broker Expo 2024 in Birmingham.